Filing Details
- Accession Number:
- 0001209191-22-051667
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-30 17:13:45
- Reporting Period:
- 2022-08-16
- Accepted Time:
- 2022-09-30 17:13:45
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1632384 | C Joseph Galante | 2525 West End Avenue Suite 950 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-08-16 | 65 | $2.35 | 50,956 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-17 | 65 | $2.31 | 51,021 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-18 | 65 | $2.23 | 51,086 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-19 | 65 | $2.35 | 51,151 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-22 | 65 | $2.51 | 51,216 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-23 | 65 | $2.59 | 51,281 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-24 | 65 | $2.59 | 51,346 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-25 | 65 | $2.62 | 51,411 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-26 | 65 | $2.55 | 51,476 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-29 | 70 | $2.44 | 51,546 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-30 | 70 | $2.38 | 51,616 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-08-31 | 70 | $2.36 | 51,686 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-01 | 70 | $2.39 | 51,756 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-02 | 70 | $2.42 | 51,826 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-06 | 70 | $2.15 | 51,896 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-07 | 70 | $2.24 | 51,966 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-08 | 40 | $2.22 | 52,036 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-09 | 70 | $2.21 | 52,076 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-12 | 70 | $2.46 | 52,146 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-13 | 70 | $2.45 | 52,216 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-14 | 70 | $2.51 | 52,286 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-15 | 70 | $2.47 | 52,356 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-16 | 70 | $2.49 | 52,426 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-19 | 65 | $2.56 | 52,491 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-20 | 65 | $2.54 | 52,556 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-21 | 65 | $2.59 | 52,621 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-22 | 65 | $2.51 | 52,686 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-23 | 65 | $2.55 | 52,751 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-26 | 65 | $2.49 | 52,816 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-09-27 | 65 | $2.57 | 52,881 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |
Footnotes
- The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.